(Q33889283)

29 July 2017

The Current Status of Gene Therapy for Prostate Cancer (English)

1 reference

29 July 2017

0 references

1 reference

Nowroozi MR

1

1 reference

PubMed ID

10761101

29 July 2017

Pisters LL

series ordinal

2

1 reference

29 July 2017

1 November 1998

1 reference

29 July 2017

1 reference

29 July 2017

5

1 reference

29 July 2017

6

1 reference

29 July 2017

522-531

1 reference

29 July 2017

Cancer statistics, 1996.

1 reference

https://api.crossref.org/works/10.1177%2F107327489800500605

The ADA human gene therapy clinical protocol: Points to Consider response with clinical protocol, July 6, 1990.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327489800500605

Gene therapy--the future is here: a guide to the practicing urologist

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327489800500605

Development of gene therapy for prostate cancer using a novel promoter of prostate-specific antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327489800500605

Development of a hammerhead ribozyme against bcl-2. I. Preliminary evaluation of a potential gene therapeutic agent for hormone-refractory human prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327489800500605

KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327489800500605

The future of gene therapy in the treatment of urologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327489800500605

The basic science of gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327489800500605

Adenoviral-mediated gene transfer of human surfactant protein B to respiratory epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327489800500605

Adenovirus mediated expression of therapeutic plasma levels of human factor IX in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327489800500605

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327489800500605

Molecular characterization of defective antigen processing in human prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327489800500605

Demonstration of a rational strategy for human prostate cancer gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327489800500605

Adenovirus-mediated herpes simplex virus thymidine kinase gene and ganciclovir therapy leads to systemic activity against spontaneous and induced metastasis in an orthotopic mouse model of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327489800500605

Prostate cancer gene therapy: herpes simplex virus thymidine kinase gene transduction followed by ganciclovir in mouse and human prostate cancer models

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327489800500605

An adenovirus mutant that replicates selectively in p53-deficient human tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327489800500605

Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327489800500605

Molecular therapy with recombinant p53 adenovirus in an androgen-independent, metastatic human prostate cancer model

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327489800500605

Human p53 gene localized to short arm of chromosome 17

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327489800500605

10.1177/107327489800500605

21 January 2018

Identifiers

DOI

0 references

PubMed ID

10761101

1 reference

PubMed ID

10761101